Males and Females 18 years and older

The trial is being conducted to determine the safety and effectiveness of the medication UBRELVY in the possible treatment of pre-headache phase of migraine attacks.

Eligibility

• 2-8 migraine days a month
• Be able to recognize the signs that a migraine will occur in the next few hours
• Must be able to distinguish migraine attacks from tension/cluster headaches
• Must use 2 acceptable methods of contraception to avoid pregnancy throughout the study

Trial Duration

The trial will last up to 4 months involving 4 visits to our office

Compensation

You will be paid via Greenphire debit card.